Utah Medical Products (UTMD) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Utah Medical Products (UTMD) over the last 14 years, with Q4 2024 value amounting to $23.9 million.
- Utah Medical Products' Accumulated Depreciation & Amortization rose 86.0% to $23.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.9 million, marking a year-over-year increase of 86.0%. This contributed to the annual value of $23.9 million for FY2024, which is 86.0% up from last year.
- As of Q4 2024, Utah Medical Products' Accumulated Depreciation & Amortization stood at $23.9 million, which was up 86.0% from $23.7 million recorded in Q4 2023.
- Over the past 5 years, Utah Medical Products' Accumulated Depreciation & Amortization peaked at $23.9 million during Q4 2024, and registered a low of $22.6 million during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $23.2 million, with a median of $22.9 million in 2022.
- As far as peak fluctuations go, Utah Medical Products' Accumulated Depreciation & Amortization surged by 62.28% in 2022, and later surged by 339.09% in 2023.
- Quarter analysis of 5 years shows Utah Medical Products' Accumulated Depreciation & Amortization stood at $22.6 million in 2020, then increased by 0.97% to $22.8 million in 2021, then increased by 0.62% to $22.9 million in 2022, then increased by 3.39% to $23.7 million in 2023, then grew by 0.86% to $23.9 million in 2024.
- Its last three reported values are $23.9 million in Q4 2024, $23.7 million for Q4 2023, and $22.9 million during Q4 2022.